What is the role of methotrexate in the aMVAC regimen?
Label:chem
Topic
Methotrexate is part of the aMVAC regimen used for neoadjuvant chemotherapy in muscle-invasive urothelial cancer.
Answer
Methotrexate is one of the key components of the aMVAC regimen. It is administered at a dose of 30 mg/m² on day one of the biweekly cycles. It helps in achieving tumor regression and is part of the combination therapy that enhances the overall efficacy of the regimen.
Return to Home
Chemical List
Knowledge you may be interested in